However, so far there is only a small amount of research focusing on the analysis of the p53 status in patients affected by RCC, and therefore there is not enough data to provide a complete picture of the TP53 mutation pattern and function when it comes to this particular cancer. This evidence concerns the gene TP53 and cancer.